Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IPF Partners is a leading alternative financing provider focused on the European healthcare sector. IPF Invest Co 2 is a specific investment vehicle (S.à r.l.) managed by the firm to facilitate debt financing and growth capital transactions. The firm typically provides non-dilutive venture debt to commercial-stage or late-clinical-stage companies in the biotechnology, medical technology, and pharmaceutical industries. IPF Partners targets companies with strong management teams and high-quality clinical data or commercial traction. The firm's portfolio includes numerous European healthcare innovators, helping them bridge the gap to profitability or major liquidity events.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IPF Invest Co 2.